Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderNot yet recruitingPhase 22025-09-08NCT07150403

1 results · Page 1 of 1

Swipe the table sideways for more columns.

45 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Bayeux ChBayeuxFrance1
Beauvais ChBeauvaisFrance1
BergoniéBordeauxFrance2
BRABOISVandœuvre-lès-NancyFrance1
Centre De Cancérologie Du Grand MontpellierMontpellierFrance4
Centre Leonard de VinciDechyFrance6
Centre Pierre CurieBeuvryFrance8
Ch Nord OuestVillefranche-sur-SaôneFrance2
Chauny ChChaunyFrance1
CHD VendéeLa Roche-sur-YonFrance41
Cholet ChCholetFrance1
Clinique de FlandreCoudekerque-BrancheFrance5
Clinique Mutualiste de l'EstuaireSaint-NazaireFrance8
Confluent SasNantesFrance2
Cote BasqueBayonneFrance1
Dijon BourgogneDijonFrance1
Docteur SchaffnerLensFrance1
Franco BritanniqueLevallois-PerretFrance1
GHPSO Site de CreilCreilFrance3
Ght Unyon AuxerreAuxerreFrance1
Groupe Hospitalier Diaconesses Croix Saint SimonParisFrance6
Gustave RoussyVillejuifFrance47
Hopital Nord Chu Saint EtienneSaint-Priest-en-JarezFrance3
Hôpital Européen G PompidouParisFrance1
ICAN Institut de Cancérologie de Strasbourg EuropeStrasbourgFrance1